The FTC open to settle the case of Amgen's billion-dollar acquisition of Horizon
![Photo: ROBERT GALBRAITH/REUTERS / X90034](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14290157.ece/ALTERNATES/schema-16_9/doc7m7ri09klp1yd8u24l6.jpg)
In May, the US Federal Trade Commission, the FTC, initiated a lawsuit to block Amgen’s purchase of Horizon Therapeutics for USD 27.8bn.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.